H.R. 6280, a healthcare bill focused on genetic counseling, gains endorsement from over 200 U.S. healthcare organizations and 500 clinicians. NSGC provides resources to advance support.
UnitedHealth Group stock struggles as rising healthcare costs pressure financial performance, highlighting key market and regulatory challenges in 2024.
CMS announces 2026 updates for OPPS and ASC payment systems, including expanded site neutral payments, skin substitute product unbundling, IPO list phase-out, and new hospital price transparency requirements.
A new poll shows growing public support for Medicare for All in the U.S., reflecting dissatisfaction with rising private insurance premiums and limitations of the Affordable Care Act.
CMS announces $12 billion savings from Medicare drug price negotiations on 15 high-cost medications, effective 2027, enhancing Medicare Part D sustainability.
CMS's 2027 proposed rule outlines key Medicare Advantage and Part D program updates, codifying Inflation Reduction Act changes, adjusting Star Ratings, and modernizing marketing and risk adjustment frameworks.
Medicare open enrollment ends soon; JABA offers free counseling to help beneficiaries review and select their 2025 Part D prescription drug plans. Nearly 3,000 people saved $4.4M on prescription costs.
Explore key strategies and programs to reduce Medicare Part D prescription medication costs in 2026, including Extra Help, state assistance, generic options, and payment plans.
New York lawmakers request health department review of Optum's network exclusions and clinic closures amid Medicaid and Medicare changes affecting healthcare access.
OIG report identifies Medicare overpayments for continuous glucose monitors and urges CMS to reduce payment rates, highlighting potential savings.
